Free Trial

Stock Price Targets and Analyst Ratings

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
The Bank of Nova Scotia stock logo
BNS
Bank of Nova Scotia
Upgraded byCIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$73.35
+1.9%
C$78.00 ➝ C$82.00Neutral ➝ Outperform
Cogeco Communications Inc. stock logo
CCA
Cogeco Communications
Upgraded byNational Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$68.12
+1.0%
C$64.00 ➝ C$80.00Sector Perform ➝ Outperform
Definity Financial Co. stock logo
DFY
Definity Financial
Target Raised byTD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$52.25
+4.8%
C$52.00 ➝ C$55.00
Definity Financial Co. stock logo
DFY
Definity Financial
Target Raised byScotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$52.25
+4.8%
C$51.00 ➝ C$53.00
Element Fleet Management Corp. stock logo
EFN
Element Fleet Management
Target Raised byTD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$28.37
-0.1%
C$30.00 ➝ C$32.00
Emera Incorporated stock logo
EMA
Emera
Target Set byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$52.48
+1.1%
C$55.00Neutral
Top 10 AI Stocks to Buy Now (Ad)

Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.

Fortis Inc. stock logo
FTS
Fortis
Target Set byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$60.60
+0.2%
C$60.00Underperform
MDA Space Ltd. stock logo
MDA
MDA Space
Target Raised byRoyal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$16.82
+2.3%
C$18.00 ➝ C$20.00
National Bank of Canada stock logo
NA
National Bank of Canada
Downgraded byCIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$127.22
-0.6%
Outperform ➝ Neutral
Oncolytics Biotech Inc. stock logo
ONC
Oncolytics Biotech
Target Raised byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C$1.26
-2.3%
C$3.00 ➝ C$3.50

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 11:17 PM ET.

(Ad)

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.